Anti-CD4 antibody treatment of patients with rheumatoid arthritis: I. Effect on clinical course and circulating T cells.
about
CD4 antibody treatment in patients with active Crohn's disease: a phase 1 dose finding study.Differential clinical efficacy of anti-CD4 monoclonal antibodies in rat adjuvant arthritis is paralleled by differential influence on NF-kappaB binding activity and TNF-alpha secretion of T cellsRegulation of immunity by anti-T-cell antibodies.Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses.To B or not to B: role of B cells in pathogenesis of arthritis in HLA transgenic mice.Intra-articular primatised anti-CD4: efficacy in resistant rheumatoid knees. A study of combined arthroscopy, magnetic resonance imaging, and histology.Restricted heterogeneity of T cell receptor transcripts in rheumatoid synovium.Immunotherapy of rheumatoid arthritis.1991 Mack Forster Award Lecture. HLA and disease: from epidemiology to immunotherapy.Novel human antibody therapeutics: the age of the Umabs.Combination chemotherapy in rheumatoid arthritisThe monoclonal CD4 antibody M-T413 inhibits cellular infection with human immunodeficiency virus after viral attachment to the cell membrane: an approach to postexposure prophylaxisProtective versus pathogenic anti-CD4 immunity: insights from the study of natural resistance to HIV infection.Reshaping a therapeutic CD4 antibody.New targets of therapy in T-cell lymphomas.Humanized anti-CD4 monoclonal antibody therapy of autoimmune and inflammatory disease.Immunointervention in psoriasis with anti-CD4 antibodies.Molecular and cellular mechanisms of joint destruction in rheumatoid arthritis: two cellular mechanisms explain joint destruction?Pharmacokinetic, pharmacodynamic and clinical effects of a humanized IgG1 anti-CD4 monoclonal antibody in the peripheral blood and synovial fluid of rheumatoid arthritis patients.Treatment of rheumatoid arthritis with anti CD4 monoclonal antibody. Open study of 25 patients with the B-F5 clone.
P2860
Q24515348-FF7F580E-7541-4950-B667-9F4E8DF4703BQ24807250-E9D942D7-1D23-44C6-8FBF-682F20ED3A96Q33558513-AA3E3C82-76C0-441C-82CE-71E52C024306Q34170327-EC232F6B-B12A-4983-8959-923D78417F25Q35214196-89D97912-A34A-45E4-91FA-D2310D726603Q35548626-502900A6-4BC9-44C0-997D-E96C9325D312Q35604657-99A1F42A-946B-4678-A3C6-DF1DA5C5FBF8Q35881647-FACDB80E-4657-4FFC-939F-0D1C0F70FBD9Q35981919-644F488B-85E2-4623-A670-4688CD873543Q37243228-1808FA6A-6B89-4791-B0DF-F5AB1AE46A7CQ37263440-A8412552-A21D-42F3-8B99-763A302D686DQ37297651-E48CA501-B937-48A1-B087-731D0C444410Q37460580-EE31C9D1-92E0-4053-A6DC-119A11F2145DQ37510930-D3186528-F5E9-4874-8A2A-2EFEBC7DF4D4Q37701472-EC39DD2D-8D98-47CC-A0FD-82EEB610F20DQ39452477-58A4A738-67C7-4155-A601-569832C435FAQ40624548-3706BEEE-04E1-4914-A361-AE87F33585CEQ40901167-6BF84FC5-3653-43A4-8145-6AD0599EBF7FQ42635758-55577BB0-3A71-4444-8E13-3C486E0A8B75Q54056758-344AEE18-E525-4C0F-BE5B-6ADA495B1487
P2860
Anti-CD4 antibody treatment of patients with rheumatoid arthritis: I. Effect on clinical course and circulating T cells.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh
1989年學術文章
@zh-hant
name
Anti-CD4 antibody treatment of ...... ourse and circulating T cells.
@en
type
label
Anti-CD4 antibody treatment of ...... ourse and circulating T cells.
@en
prefLabel
Anti-CD4 antibody treatment of ...... ourse and circulating T cells.
@en
P2093
P1476
Anti-CD4 antibody treatment of ...... ourse and circulating T cells.
@en
P2093
Pichler WJ
Riethmüller G
Stockinger H
P304
P356
10.1016/S0896-8411(89)80002-2
P577
1989-10-01T00:00:00Z